Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
CCash | ||
Medacta Group SA (XSWX:MOVE) Full Year 2025 Earnings Call Highlights: Robust Growth and ... Medacta Group SA (XSWX:MOVE) reports strong financial performance with significant revenue growth and strategic expansion plans despite market challenges. | ||
CCash | ||
 Should You Think About Buying Medacta Group SA (VTX:MOVE) Now? While Medacta Group SA ( VTX:MOVE ) might not have the largest market cap around , it saw significant share price... | ||
Medacta Group (VTX:MOVE) shareholders have earned a 12% CAGR over the last five years Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make... | ||
Its Easy to Overlook Medacta Group SA (VTX:MOVE) But Its Strong Financial Prospects Might Make You Want To Stop and Notice It is easy to overlook Medacta Group's (VTX:MOVE) given its unimpressive and roughly flat price performance over the... | ||
CCash | ||
The Return Trends At Medacta Group (VTX:MOVE) Look Promising If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common... | ||
There May Be Underlying Issues With The Quality Of Medacta Group's (VTX:MOVE) Earnings Medacta Group SA ( VTX:MOVE ) just reported some strong earnings, and the market reacted accordingly with a healthy... | ||
 Medacta Group First Half 2025 Earnings: EPS: €3.01 (vs €1.91 in 1H 2024) Medacta Group ( VTX:MOVE ) First Half 2025 Results Key Financial Results Revenue: €344.1m (up 19% from 1H 2024). Net... | ||
What Is Medacta Group SA's (VTX:MOVE) Share Price Doing? While Medacta Group SA ( VTX:MOVE ) might not have the largest market cap around , it saw a decent share price growth... | ||